These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 741900)

  • 1. [Plasma hydroxyproline determination in patients with metabolic diseases of the bone collagen].
    Leicht E; Langer HJ; Stelzer K; Blum C
    Verh Dtsch Ges Inn Med; 1978; (84):1115-9. PubMed ID: 741900
    [No Abstract]   [Full Text] [Related]  

  • 2. Collagen metabolism, uremia and bone.
    Avioli LV
    Kidney Int; 1973 Aug; 4(2):105-15. PubMed ID: 4598143
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum and urinary hydroxyproline in patients with severe chronic renal failure.
    Jungiewicz R; Tomaszewski J
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():67-73. PubMed ID: 3154061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E; Lüke F; Heidland A
    Med Klin; 1976 Nov; 71(45):1945-51. PubMed ID: 995035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary hydroxyproline and the metabolism of collagen].
    Kivirikko KI
    Duodecim; 1969; 85(18):1108-19. PubMed ID: 5371391
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA
    Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary hydroxyproline and the bone in primary and secondary hyperparathyroidism.
    Johnston NG; Lee CA; Lloyd HM
    Metabolism; 1966 Dec; 15(12):1084-91. PubMed ID: 5960947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)].
    Sebert JL; Fournier A; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(37):3419-24. PubMed ID: 341075
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic studies with 14-C-hydroxyproline in osteopathies of chronic renal failure.
    Constantinides C; Kostamis P; Ktoros D; Malamos B
    Int J Appl Radiat Isot; 1970 Jan; 21(1):21-5. PubMed ID: 5415008
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of progressive end-stage renal insufficiency on bone mineral-collagen maturation.
    Russell JE; Avioli LV
    Kidney Int Suppl; 1975 Jan; (2):97-101. PubMed ID: 1099309
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of free and total hydroxyproline by automated flow injection of serum or urine samples from maintenance hemodialysis patients with renal osteodystrophy.
    Uji Y; Karmen A; Okabe H; Hata K; Miura M; Ozaki K; Minamizaki M; Shibata T; Inayama S
    J Clin Lab Anal; 1994; 8(5):267-72. PubMed ID: 7807280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
    Wiegmann T; Kirsh J; Rosenthall L; Kaye M
    J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intestinal absorption of 47Ca by patients in chronic renal failure.
    Ogg CS
    Clin Sci; 1968 Jun; 34(3):467-71. PubMed ID: 5666875
    [No Abstract]   [Full Text] [Related]  

  • 15. Iminoacidopathy in renal failure.
    Simon NM; Bell NH; Del Greco F
    Arch Intern Med; 1970 Feb; 125(2):299-301. PubMed ID: 5412018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 17. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of calcium phosphate homeostasis in patients with intermittent hemodialysis therapy].
    Pogglitsch H; Holzer H; Giessauf W; Stöckl G
    Wien Med Wochenschr; 1972 May; 122(22):311-7. PubMed ID: 5045838
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone collagen metabolism in uremia--studies of plasma hydroxyproline level in chronic, non-dialyzed kidney disease].
    Heidbreder E; Lüke F; Heidland A
    Verh Dtsch Ges Inn Med; 1975; 81():971-4. PubMed ID: 1229629
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A; McChesney R; Irvine RO; Dixon SR
    N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.